Indeed, Sun et al. have shown that N-cadherin deficiency converts the tumor microenvironment from immunotherapy resistant to responsive through decreasing PD-L1 and IDO-1 levels, and by inhibition of effector Treg production [271]. Here, CDH2 is linked to neoplasm.